Cummings, J., Lee, G., Ritter, A. & Zhong, K. Alzheimer’s disease drug development pipeline: 2018. Alzheimers Dement. (NY) 4, 195–214 (2018).
Henstridge, C. M., Hyman, B. T. & Spires-Jones, T. L. Beyond the neuron–cellular interactions early in Alzheimer disease pathogenesis. Nat. Rev. Neurosci. 20, 94–108 (2019).
Knopman, D. S. Lowering of amyloid-beta by β-secretase inhibitors—some informative failures. N. Engl. J. Med. 380, 1476–1478 (2019).
Boyle, P. A. et al. Attributable risk of Alzheimer’s dementia attributed to age-related neuropathologies. Ann. Neurol. 85, 114–124 (2019).